AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS' COMPREHENSIVE DIABETES MANAGEMENT ALGORITHM 2013 CONSENSUS STATEMENT - EXECUTIVE SUMMARY

被引：161

作者：

Garber, Alan J. ^{[1
]}

Abrahamson, Martin J. ^{[1
]}

Barzilay, Joshua I. ^{[1
]}

Blonde, Lawrence ^{[1
]}

Bloomgarden, Zachary T. ^{[1
]}

Bush, Michael A. ^{[1
]}

Dagogo-Jack, Samuel ^{[1
]}

Davidson, Michael B. ^{[1
]}

Einhorn, Daniel ^{[1
]}

Garvey, W. Timothy ^{[1
]}

Grunberger, George ^{[1
]}

Handelsman, Yehuda ^{[1
]}

Hirsch, Irl B. ^{[1
]}

Jellinger, Paul S. ^{[1
]}

McGill, Janet B. ^{[1
]}

Mechanick, Jeffrey I. ^{[1
]}

Rosenblit, Paul D. ^{[1
]}

Umpierrez, Guillermo E. ^{[1
]}

Davidson, Michael H. ^{[1
]}

机构：

[1] Amer Assoc Clin Endocrinologists, Jacksonville, FL 32202 USA

来源：

ENDOCRINE PRACTICE | 2013年 / 19卷 / 03期

关键词：

CORONARY-HEART-DISEASE; CONTROLLED-RELEASE PHENTERMINE/TOPIRAMATE; BLOOD-PRESSURE TARGETS; HUMAN NPH INSULIN; ADD-ON THERAPY; BASAL INSULIN; MYOCARDIAL-INFARCTION; PRIMARY-PREVENTION; LDL CHOLESTEROL; HYPERCHOLESTEROLEMIC PATIENTS;

D O I：

10.4158/EP13176.CS

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：536 / 547

页数：12

共 109 条

[31] Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis [J].

Deacon, C. F. ;

Mannucci, E. ;

Ahren, B. .

DIABETES OBESITY & METABOLISM, 2012, 14 (08) :762-767

[32] Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review [J].

Deacon, C. F. .

DIABETES OBESITY & METABOLISM, 2011, 13 (01) :7-18

[33] Bromocriptine: A Sympatholytic, D2-Dopamine Agonist for the Treatment of Type 2 Diabetes [J].

DeFronzo, Ralph A. .

DIABETES CARE, 2011, 34 (04) :789-794

[34] Sequential Intensification of Metformin Treatment in Type 2 Diabetes With Liraglutide Followed by Randomized Addition of Basal Insulin Prompted by A1C Targets [J].

DeVries, J. Hans ;

Bain, Stephen C. ;

Rodbard, Helena W. ;

Seufert, Jochen ;

D'Alessio, David ;

Thomsen, Anne B. ;

Zychma, Marcin ;

Rosenstock, Julio .

DIABETES CARE, 2012, 35 (07) :1446-1454

[35] Outpatient insulin therapy in type 1 and type 2 diabetes mellitus - Scientific review [J].

DeWitt, DE ;

Hirsch, IB .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (17) :2254-2264

[36]

Diabetes Prevention Progam, 2005, DIABETES, V54, P1150

[37] Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial [J].

Dormandy, JA ;

Charbonnel, B ;

Eckland, DJA ;

Erdmann, E ;

Massi-Benedetti, M ;

Kmoules, IK ;

Skene, AM ;

Tan, MH ;

Lefébvre, PJ ;

Murray, GD ;

Standl, E ;

Wilcox, RG ;

Wlhelmsen, L ;

Betteridge, J ;

Birkeland, K ;

Golay, A ;

Heine, RJ ;

Korányi, L ;

Laakso, M ;

Mokán, M ;

Norkus, A ;

Pirags, V ;

Podar, T ;

Scheen, A ;

Scherbaum, W ;

Schernthaner, G ;

Schmitz, O ;

Skrha, J ;

Smith, U ;

Taton, J .

LANCET, 2005, 366 (9493) :1279-1289

[38] Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes [J].

Duckworth, William ;

Abraira, Carlos ;

Moritz, Thomas ;

Reda, Domenic ;

Emanuele, Nicholas ;

Reaven, Peter D. ;

Zieve, Franklin J. ;

Marks, Jennifer ;

Davis, Stephen N. ;

Hayward, Rodney ;

Warren, Stuart R. ;

Goldman, Steven ;

McCarren, Madeline ;

Vitek, Mary Ellen ;

Henderson, William G. ;

Huang, Grant D. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (02) :129-U62

[39]

Espeland M, 2007, DIABETES CARE, V30, P1374

[40]

Ferwana M, 2013, DIABET MED IN PRESS

← 1 2 3 4 5 6 7 8 9 10 →